Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin study (REGRESS). - Jukema,J.W.; Bruschke,A.VG.; van Boven,A.J.; Reiber,H.C.; Bal,E.T.; Zwinderman,A.H.; Jansen,H.; Boerma,G.JM.; van Rappard,F.M.; Lie,K.I; on behalf of the REGRESS Study group. (Circulation, 1995)